HALO logo
BIOG.B
BioGaia AB Class B

BIOG.B · BioGaia AB Class B

122.10

SEK
0.70 (0.577%)
14/10/2026 12:00:00 AM
+1
Price change (7D)

Unlock stock Insights

Create a free account to unlock price targets, recommendations, and commentary.

Overview

Market Cap

kr11.50B

PE

32.30

EV/EBITDA

20.9

DIV Yield

1.5%

Payout Ratio

50%

MQV Rating

4Weak

As at 14/10/2026 12:00:00 AM

Price Chart

Description

BioGaia AB engages in the development, marketing, and sale of probiotic products. It operates through the following segments: Pediatrics, Adult Health, and Other. The Pediatrics segment sells drops, oral rehydration solutions, digestive health tablets, and also royalties pertaining to pediatric products. The Adult Health segment include gut health tablets, oral health products, and offers cultures as an ingredient in a licensee's dairy product. The Other segment consists royalties from the development projects, and revenue from packaging solutions. The company was founded by Jan Annwall and Peter Michael Rothschild in 1990 and is headquartered in Stockholm, Sweden.

  • All-Companies
  • All-Consensus
  • HALO 200
  • HALO All
  • HALO Balance Sheet
  • HALO Capital Efficiency
  • HALO Small
  • HALO Yield

Key Fundamentals

EPS 3 yr Growth

-11.10%

EBITDA Margin

31.00%

Operating Cashflow

kr307m

Free Cash Flow Return

20.20%

ROIC

21.90%

Interest Coverage

78.70

Quick Ratio

5.30

Performance

52 weeks range

Low 96.2 - 136.3

Trade Value (12mth)

US$600,464.00

1 week

2.46%

1 month

8.55%

YTD

11.24%

1 year

7.95%

All time high

139.70

Additional Data

Shares Outstanding (Fully Diluted)

101m

HALO Sector

Healthcare

Next Company Report Date

12-Feb-27

Next Ex Dividend Date

08-May-26

Next Dividend Pay Date

15-May-26

Reporting Currency

SEK

Short Sell (% of issue)

0.00

Consensus

Lock Icon

Unlock full consensus

Consensus score

Lock Icon/10

Recommendation

Buy

Target price

Lock Icon

Deviation

Lock Icon

Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Very Strong

Halo Model

Mqv

Weak

Garp

Weak

Mqv Small

Neutral

Momentum

Price

Neutral

Earnings

Weak

Growth

Earnings

Weak

Dividends

Strong

Quality

Capital Efficiency

Very Strong

Balance Sheet

Very Strong

Valuation

Lock Icon

Unlock full dataset

Value

Lock Icon

Consensus

Lock Icon

Yield

Lock Icon

News & Announcements

No announcements available.

Key Stakeholders

NameTitle
Anatom Holding AGPrivate Company
Patricia KahaneIndividual
Corvatsch Invest AGPrivate Company
David E. R. DangoorIndividual
Mauricio GraberIndividual

See beyond the curve.

One solution for research, investing and model portfolio management.
Start FREE Trial
Want to learn more?Frequently asked questions.
1
What is the current share price of BioGaia AB Class B (BIOG.B:OME)?
Halo FAQ
The current share price of BioGaia AB Class B (BIOG.B:OME) is SEKkr122.10.
2
What is the 52-week high share price for BioGaia AB Class B (BIOG.B:OME)?
Halo FAQ
The 52-week high share price for BioGaia AB Class B (BIOG.B:OME) is SEKkr136.30.
3
What is the 52-week low share price for BioGaia AB Class B (BIOG.B:OME)?
Halo FAQ
The 52-week low share price for BioGaia AB Class B (BIOG.B:OME) is SEKkr96.20.
4
What is the dividend yield for BioGaia AB Class B (BIOG.B:OME)?
Halo FAQ
The current TTM dividend payout for BioGaia AB Class B (BIOG.B:OME) is 1.50.
5
What was BioGaia AB Class B (BIOG.B:OME) last dividend payment?
Halo FAQ
The last dividend payment of BioGaia AB Class B (BIOG.B:OME) is SEKkr4.00.
6
What is the franking level for BioGaia AB Class B (BIOG.B:OME)?
Halo FAQ
BioGaia AB Class B (BIOG.B:OME) has a franking level of 0.00%.
7
In which sector is BioGaia AB Class B (BIOG.B:OME) classified?
Halo FAQ
BioGaia AB Class B (BIOG.B:OME) is classified in the Healthcare.
8
What is the price-to-earnings (P/E) ratio for BioGaia AB Class B (BIOG.B:OME)?
Halo FAQ
The current P/E ratio for BioGaia AB Class B (BIOG.B:OME) is 32.30.